FDA Panel: All Thumbs Down for Amphetamine Product Meant to Deter Abuse

(MedPage Today) -- An FDA advisory committee voted unanimously Thursday that the risks of a novel amphetamine designed to deter abuse outweighed the benefits, concluding it may in fact be misused and could be even more dangerous than conventional...